Germany, EU, join U.S. in banning India-made Ranbaxy products – FiercePharma Manufacturing

Following years after actions by the U.S., Germany and EU regulators have banned Ranbaxy Laboratories from exporting the injectable versions of its cephalosporin antibiotics following an inspection earlier this year of the company’s plant in central India.

Read more – FiercePharma Manufacturing